Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. Company
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Delayed Quote. Delayed Xetra - 12/03 11:35:14 am
213.6 EUR   +0.52%
12/03MARKETMIND : Omicron and payrolls (TGIF)
RE
12/02MARKETMIND : Vol takes a toll
RE
12/01MARKETMIND : Transitory, you are toast
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Number of employees : 58 096 people.
Sales per Business
20192020Delta
Life Science6 864.0042.5%7 515.0042.9% +9.48%
Healthcare6 714.0041.6%6 639.0037.9% -1.12%
Performance Materials2 574.0015.9%3 380.0019.3% +31.31%
EUR in Million
Sales per region
20192020Delta
United States4 101.0025.4%4 639.0026.5% +13.12%
Asia Pacific3 250.0020.1%3 738.0021.3% +15.02%
Europe3 369.0020.9%3 552.0020.3% +5.43%
China2 048.0012.7%2 224.0012.7% +8.59%
Germany1 475.009.1%1 501.008.6% +1.76%
Latin America965.006%868.005% -10.05%
Switzerland389.002.4%462.002.6% +18.77%
Middle East and Africa373.002.3%361.002.1% -3.22%
North America182.001.1%191.001.1% +4.95%
EUR in Million
Managers
Name Title Age Since
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO 60 2021
Marcus Kuhnert Chief Financial Officer 52 2014
Maria Rivas Chief Medical Officer & Senior Vice President 56 -
Laura Matz Chief Science & Technology Officer - 2021
Nilesh Kumar Senior Investment Director 43 2009
Christian Raabe, Dr. Member-Supervisory Board - 2019
Edeltraud Glńnzer Member-Supervisory Board 65 2008
JŘrgen Glaser Member-Supervisory Board 59 2012
Helga RŘbsamen-Schaeff, Dr. Member-Supervisory Board 72 2014
Gabriele Eismann, Dr. Member-Supervisory Board 60 2014
Members of the board
Name Title Age Since
Wolfgang BŘchele Chairman-Supervisory Board 62 2014
Christian Raabe, Dr. Member-Supervisory Board - 2019
Edeltraud Glńnzer Member-Supervisory Board 65 2008
JŘrgen Glaser Member-Supervisory Board 59 2012
Helga RŘbsamen-Schaeff, Dr. Member-Supervisory Board 72 2014
Gabriele Eismann, Dr. Member-Supervisory Board 60 2014
Dietmar Oeter, Dr. Member-Supervisory Board 55 2014
Alexander Putz Member-Supervisory Board 55 2020
Helene von Roeder Member-Supervisory Board 51 2019
Sascha Held Vice Chairman-Supervisory Board - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 129,242,252 129,242,252 100.0% 0 0.0% 29.7%
Stock B 1 305,535,626 0 0.0% 0 0.0%
Shareholders
NameEquities%
Massachusetts Financial Services Co. 6,342,586 4.91%
Fidelity Management & Research Co. LLC 3,850,095 2.98%
Select Equity Group LP 3,832,793 2.97%
The Vanguard Group, Inc. 3,409,896 2.64%
McKinley Capital Management LLC 3,348,185 2.59%
DWS Investment GmbH 2,804,195 2.17%
Norges Bank Investment Management 2,542,168 1.97%
Schroder Investment Management Ltd. 1,795,275 1.39%
Thornburg Investment Management, Inc. 1,576,735 1.22%
Capital Research & Management Co. (World Investors) 1,491,894 1.15%
Holdings
NameEquities%Valuation
PRECIGEN, INC. (PGEN) 20,647,152 9.99% 99,725,744 USD
PT MERCK TBK 388,194,920 86.7% 95,352,318 USD
VERA THERAPEUTICS, INC. (VERA) 1,913,501 9.13% 37,026,244 USD
GALECTO, INC. (GLTO) 1,239,030 4.90% 4,088,799 USD
PROGYNY, INC. (PGNY) 45,000 0.050% 2,764,350 USD
Markets and indexes
- Prime Standard
- DAX 30 / PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  MRK:GR
- Reuters Code :  MRCG.DE
- Datastream Code :  D:MRK
Company contact information
Merck KGaA
Frankfurter Strasse 250
DE-64293 Darmstadt, Hessen

Phone : +49 (0)6151 72 0
Fax : +49 (0)6151 72 2000
web site : http://www.merck.de
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck KGaA